Amyloid precursor protein and mitochondrial dysfunction in Alzheimer's disease

Neuroscientist

Volumn 13, Issue 6, 2007, Pages 626-638

  Anandatheerthavarada, Hindupur K ^a   Devi, Latha ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

A ; Acidic domain; Alzheimer's disease; Amyloid precursor protein; Import channels; Mitochondria; Mitochondrial dysfunction; Transgenic mouse models; Translocational arrest

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ISOPROTEIN;

ALZHEIMER DISEASE; BRAIN; BRAIN MITOCHONDRION; BRAIN NERVE CELL; CARBOXY TERMINAL SEQUENCE; CELL COMPARTMENTALIZATION; CELL FUNCTION; CELL TRANSPORT; DEPRESSION; DISEASE ASSOCIATION; DISEASE MODEL; HUMAN; MITOCHONDRIAL GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN METABOLISM; PROTEIN SECRETION; PROTEIN TRANSPORT; PSYCHOSIS; REVIEW; SIGNAL TRANSDUCTION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; HUMANS; MITOCHONDRIA; MITOCHONDRIAL DISEASES; MODELS, BIOLOGICAL;

EID: 35948969760     PISSN: 10738584     EISSN: 10894098     Source Type: Journal    
DOI: 10.1177/1073858407303536     Document Type: Review

References (70)

1. Abramov AY, Canevari L., Duchen MR 2004. βAmyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase. J Neurosci 24: 565-75.
2. Addya S., Anandatheerthavarada HK, Biswas G., Bhagwat SV, Mullick J., Avadhani NG 1997. Targeting of NH2-terminal-processed microsomal protein to mitochondria: a novel pathway for the biogenesis of hepatic mitochondrial P450MT2. J Cell Biol 139: 589-99.
3. Anandatheerthavarada HK, Biswas G., Mullick J., Sepuri NB, Otvos L., Pain D., and others. 1999. Dual targeting of cytochrome P4502B1 to endoplasmic reticulum and mitochondria involves novel signal activation by cyclic AMP-dependent phosphorylation at ser128. EMBO J 18: 5494-504.
4. Anandatheerthavarada HK, Biswas G., Robin MA, Avadhani NG 2003. Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells. J Cell Biol 161: 41-54.
5. Annaert WG, Levesque L., Craessaerts K., Dierinck I., Snellings G., Westaway D., and others. 1999. Presenilin 1 controls gamma-secretase processing of amyloid precursor protein in pre-golgi compartments of hippocampal neurons. J Cell Biol 147: 277-94.
6. Askanas V., McFerrin J., Baque S., Alvarez RB, Sarkozi E., Engel WK 1996. Transfer of beta-amyloid precursor protein gene using adenovirus vector causes mitochondrial abnormalities in cultured normal human muscle. Proc Natl Acad Sci USA 93: 1314-9.
7. Bahmanyar S., Higgins GA, Goldgaber D., Lewis DA, Morrison JH, Wilson MC, and others. 1987. Localization of amyloid beta protein messenger RNA in brains from patients with Alzheimer's disease. Science 237: 77-80.
8. Baloyannis SJ 2006. Mitochondrial alterations in Alzheimer's disease. J Alzheimer's Dis 9: 119-26.
9. Basun H., Forssell LG, Wetterberg L., Winblad B. 1991. Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer's disease. J Neural Transm Park Dis Dement Sect 3: 231-58.
10. Beal MF 1998. Mitochondrial dysfunction in neurodegenerative diseases. Biochim Biophys Acta 1366: 211-23.
11. Beal MF 2005. Mitochondria take center stage in aging and neurodegeneration. Ann Neurol 58: 495-505.
12. Borchelt DR, Thinakaran G., Eckman CB, Lee MK, Davenport F., Ratovitsky T., and others. 1996. Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. Neuron 17: 1005-13.
13. Busciglio J., Pelsman A., Wong C., Pigino G., Yuan M., Mori H., and others. 2002. Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down's syndrome. Neuron 33: 677-88.
14. Casley CS, Canevari L., Land JM, Clark JB, Sharpe MA 2002. Beta-amyloid inhibits integrated mitochondrial respiration and key enzyme activities. J Neurochem 80: 89-100.
15. Caspersen C., Wang N., Yao J., Sosunov A., Chen X., Lustbader JW, and others. 2005. Mitochondrial Aβ: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease. FASEB J 19: 2040-1.
16. Chang S., Ma T., Miranda D., Balestra ME, Mahley RW, Huang Y. 2005. Lipid- and receptor-binding domains of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity. Proc Natl Acad Sci USA 102: 18694-9.
17. Chen H., Chan DC 2005. Emerging functions of mammalian mitochondrial fusion and fission. Human Mol Gen 15 (2). R283-9.
18. Crouch PJ, Blake R., Duce JA, Ciccotosto GD, Li QX, Barnham KJ, and others. 2005. Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-beta1-42. J Neurosci 25: 672-9.
19. Cummings JL 2000. Cognitive and behavioral heterogeneity in Alzheimer's disease: seeking the neurobiological basis. Neurobiol Aging 21: 845-61.
20. David DC, Hauptmann S., Scherping I., Schuessel K., Keil U., Rizzu P., and others. 2005. Proteomic and functional analysis reveal a mitochondrial dysfunction in P301L Tau transgenic mice. J Biol Chem 280: 23802-14.
21. Devi L., Prabhu BM, Galati DF, Avadhani NG, Anandatheerthavarada HK 2006. Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction. J Neurosci 30: 9057-68.
22. Ellison DW, Beal MF, Mazurek MF, Bird ED, Martin JB 1986. A postmortem study of amino acid neurotransmitters in Alzheimer's disease. Ann Neurol 20: 616-21.
23. Endo T., Yamamoto H., Esaki M. 2003. Functional cooperation and separation of translocators in protein import into mitochondria, the double-membrane bounded organelles. J Cell Sci 116: 3259-67.
24. Falkevall A., Alikhani N., Bhushan S., Pavlov PF, Busch K., Johnson KA, and others. 2006. Degradation of the amyloid beta protein by the novel mitochondrial peptidasome, PreP. Biol Chem 281: 29096-104.
25. Gabaldon T., Huynen MA 2004. Shaping the mitochondrial proteome. Biochem Biophys Acta 1659: 212-20.
26. Gouras GK, Almeida CG, Takahashi RH 2005. Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease. Neurobiol Aging 26: 1235-44.
27. Grant SM, Shankar SL, Chalmers-Redman RM, Tatton WG, Szyf M., Cuello AC 1999. Mitochondrial abnormalities in neuroectodermal cells stably expressing human amyloid precursor protein (hAPP751). Neuroreport 18: 41-6.
28. Hansson CA, Frykman S., Farmery MR, Tjernberg LO, Nilsberth C., Pursglove SE, and others. 2004. Nicastrin, presenilin, APH-1, and PEN-2 form active gamma-secretase complexes in mitochondria. J Biol Chem 279: 51654-60.
29. Hashimoto Y., Niikura T., Ito Y., Nishimoto I. 2000. Multiple mechanisms underlie neurotoxicity by different types of Alzheimer's disease mutations of amyloid precursor protein. J Biol Chem 275: 34541-51.
30. Janus C., Westaway D. 2001. Transgenic mouse models of Alzheimer's disease. Physiol Behav 73: 873-86.
31. Jeong SJ, Kim K., Suh YH 1997. Age-related changes in the expression of Alzheimer's beta APP in the brain of senescence accelerated mouse (SAM)-P/10. Neuroreport 8: 1733-7.
32. Keil U., Bonert A., Marques CA, Scherping I., Weyermann J., Strosznajder JB, and others. 2004. Amyloid beta-induced changes in nitric oxide production and mitochondrial activity lead to apoptosis. J Biol Chem 279: 50310-20.
33. Leissring MA, Farris W., Wu X., Christodoulou DC, Haigis MC, Guarente L., and others. 2004. Alternative translation initiation generates a novel isoform of insulin-degrading enzyme targeted to mitochondria. Biochem J 383: 439-46.
34. Lin MT, Beal MF 2006. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443: 787-95.
35. Loeffler DA, LeWitt PA, Juneau PL, Sima AA, Nguyen HU, DeMaggio AJ, and others. 1996. Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders. Brain Res 738: 265-74.
36. Lovell MA, Robertson JD, Teesdale WJ, Campbell JL, Markesbery WR 1998. Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci 158: 47-52.
37. Lustbader JW, Cirilli M., Lin C., Xu HW, Takuma K., Wang N., and others. 2004. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science 304: 448-52.
38. Manczak M., Anekonda TS, Henson E., Park BS, Quinn J., Reddy PH 2006. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum Mol Genet 15: 1437-49.
39. Manfredi G., Beal MF 2000. The role of mitochondria in the pathogenesis of neurodegenerative diseases. Brain Pathol 10: 462-72.
40. Mattson MP 1997. Central role of oxyradicals in the mechanism of Amyloid β-peptide toxicity. Alzheimer's Disease Review 2: 1-14.
41. Maurer I., Zierz S., Moller HJ 2000. A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients. Neurobiol Aging 21: 455-62.
42. McDermott JR, Smith AI, Iqbal K., Wisniewski HM 1979. Brain aluminum in aging and Alzheimer disease. Neurology 29: 809-14.
43. Mohs RC 1996. The Alzheimer's disease assessment scale. Int Psychogeriatr 8: 195-203.
44. Nazarali AJ, Reynolds GP 1992. Monoamine neurotransmitters and their metabolites in brain regions in Alzheimer's disease: a postmortem study. Cell Mol Neurobiol 12: 581-7.
45. Nicholls DJ, Budd SL 2000. Mitochondria and neuronal survival. Physiol Rev 80 (1). 315-60.
46. Nunan J., Small DH 2000. Regulation of APP cleavage by alpha-, beta-and gamma-secretases. FEBS Letters 24184: 1-5
47. Offen D., Elkon H., Melamed E. 2000. Apoptosis as a general cell death pathway in neurodegenerative diseases. J Neural Transm 58: 153-66.
48. Park HJ, Kim SS, Seong YM, Kim KH, Goo HG, Yoon EJ, and others. 2006. Amyloid precursor protein is a direct cleavage target of HtrA2 serine protease. J Biol Chem 281: 34277-87.
49. Parker WD Jr. 1991. Cytochrome oxidase deficiency in Alzheimer's disease. Ann NY Acad Sci 640: 59-64.
50. Prabu SK, Anandatheerthavarada HK, Raza H., Srinivasan S., Spear JF, Avadhani NG 2006. Protein kinase A-mediated phosphorylation modulates cytochrome c oxidase function and augments hypoxia and myocardial ischemia-related injury. J Biol Chem 281: 2061-70.
51. Price DL, Sisodia SS 1998. Mutant genes in familial Alzheimer's disease and transgenic models. Annu Rev Neurosci 21: 479-505.
52. Reddy PH 2006. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease. J Neurochem 96: 1-13.
53. Reddy PH, Beal MF 2005. Are mitochondria critical in the pathogenesis of Alzheimer's disease? Brain Res Brain Res Rev 49: 618-32.
54. Rehling P., Wiedemann N., Pfanner N., Truscott KN 2001. The mitochondrial import machinery for preproteins. Crit Rev Biochem Mol Biol 36: 291-336.
55. Reinikainen KJ, Soininen H., Riekkinen PJ 1990. Neurotransmitter changes in Alzheimer's disease: implications to diagnostics and therapy. J Neurosci Res 27: 576-86.
56. Robin MA, Anandatheerthavarada HK, Biswas G., Naresh Babu VS, Gordon DM, Pain D., and others. 2002. Bimodal targeting of microsomal CYP2E1to mitochondria through activation of an N-terminal chimeric signal by cAMP mediated phosphorylation. J Biol Chem 277: 40583-93.
57. Roesch K., Curran SP, Tranebjaerg L., Koehler CM 2002. Human deafness dystonia syndrome is caused by a defect in assembly of the DDP1/TIMM8a-TIMM13 complex. Hum Mol Genet 11: 477-86.
58. Ronnett GV, Hester LD, Nye JF, Conners K., Snyder SH 1990. Human cortical neuronal cell line: establishment from a patient with unilateral megalencephaly. Science 248: 603-5.
59. Selkoe DJ 1999. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399: 23-31.
60. Shepherd CE, Bowes S., Parkinson D., Cambray-Deakin M., Pearson RC 2000. Expression of amyloid precursor protein in human astrocytes in vitro: isoform-specific increases following heat shock. Neuroscience 99: 317-25.
61. Sims NR 1996. Energy metabolism, oxidative stress and neuronal degeneration in Alzheimer's disease. Neurodegeneration 5: 435-40.
62. Stephenson DT, Rash K., Clemens JA 1992. Amyloid precursor protein accumulates in regions of neurodegeneration following focal cerebral ischemia in the rat. Brain Res 593: 128-35.
63. Sue W., Griffin T. 2006. Inflammation and neurodegenerative diseases. Am J Clin Nutr 83 (suppl): 470S - 4S.
64. Tabira T., Chui DH, Kuroda S. 2002. Significance of intracellular Abeta42 accumulation in Alzheimer's disease. Front Biosci 7: 44-9.
65. Taylor SW, Fahy E., Zhang B., Glenn GM, Warnock DE, Wiley S., and others. 2003. Characterization of the human heart mitochondrial proteome. Nat Biotechnol 21: 281-6.
66. Thinakaran GJ 1999. The role of presenilins in Alzheimer's disease. Clin Invest 104: 1321-7.
67. Truscott KN, Pfanner N., Voos W. 2001. Transport of proteins into mitochondria. Rev Physiol Biochem Pharmacol 143: 81-136.
68. Xu J., Chen S., Ahmed H., Chen H., Ku G., Goldberg MP, and others. 2001. Amyloid-β peptides are cytotoxic to oligodendrocytes. J Neurosci 21: RC118: 1-5.
69. Yamaguchi H., Yamazaki T., Ishiguro K., Shoji M., Nakazato Y., Hirai S. 1992. Ultrastructural localization of Alzheimer amyloid beta/A4 protein precursor in the cytoplasm of neurons and senile plaque-associated astrocytes. Acta Neuropathol 85: 15-22.
70. Zubenko GS 2000. Neurobiology of major depression in Alzheimer's disease. Int Psychogeriatr 12: 217-30.